Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 384

1.

The promise of targeted {alpha}-particle therapy.

Mulford DA, Scheinberg DA, Jurcic JG.

J Nucl Med. 2005 Jan;46 Suppl 1:199S-204S. Review.

PMID:
15653670
[PubMed - indexed for MEDLINE]
Free Article
2.

Targeted alpha-therapy: past, present, future?

Brechbiel MW.

Dalton Trans. 2007 Nov 21;(43):4918-28. Epub 2007 Sep 11. Review.

PMID:
17992276
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Current status of therapy of solid tumors: brain tumor therapy.

Zalutsky MR.

J Nucl Med. 2005 Jan;46 Suppl 1:151S-6S. Review.

PMID:
15653663
[PubMed - indexed for MEDLINE]
Free Article
4.

Radioimmunotherapy with alpha-particle emitting radionuclides.

Zalutsky MR, Pozzi OR.

Q J Nucl Med Mol Imaging. 2004 Dec;48(4):289-96. Review.

PMID:
15640792
[PubMed - indexed for MEDLINE]
Free Article
5.

The promise of immuno-PET in radioimmunotherapy.

Verel I, Visser GW, van Dongen GA.

J Nucl Med. 2005 Jan;46 Suppl 1:164S-71S. Review.

PMID:
15653665
[PubMed - indexed for MEDLINE]
Free Article
6.

Radioimmunodetection and therapy of breast cancer.

DeNardo SJ.

Semin Nucl Med. 2005 Apr;35(2):143-51. Review.

PMID:
15765377
[PubMed - indexed for MEDLINE]
7.

An overview of targeted alpha therapy.

Kim YS, Brechbiel MW.

Tumour Biol. 2012 Jun;33(3):573-90. doi: 10.1007/s13277-011-0286-y. Epub 2011 Dec 6. Review.

PMID:
22143940
[PubMed - indexed for MEDLINE]
8.

Targeted alpha therapy: part I.

Elgqvist J.

Curr Radiopharm. 2011 Jul;4(3):176.

PMID:
22201706
[PubMed - indexed for MEDLINE]
9.

Radioimmunotherapy of solid tumors: the promise of pretargeting strategies using bispecific antibodies and radiolabeled haptens.

Reilly RM.

J Nucl Med. 2006 Feb;47(2):196-9. Review. No abstract available.

PMID:
16455623
[PubMed - indexed for MEDLINE]
Free Article
10.

Antibody-based targeted radiation to pediatric tumors.

Modak S, Cheung NK.

J Nucl Med. 2005 Jan;46 Suppl 1:157S-63S. Review.

PMID:
15653664
[PubMed - indexed for MEDLINE]
Free Article
11.

Current status and perspectives in alpha radioimmunotherapy.

Chérel M, Davodeau F, Kraeber-Bodéré F, Chatal JF.

Q J Nucl Med Mol Imaging. 2006 Dec;50(4):322-9. Review.

PMID:
17043629
[PubMed - indexed for MEDLINE]
Free Article
12.

Cancer radioimmunotherapy with alpha-emitting nuclides.

Couturier O, Supiot S, Degraef-Mougin M, Faivre-Chauvet A, Carlier T, Chatal JF, Davodeau F, Cherel M.

Eur J Nucl Med Mol Imaging. 2005 May;32(5):601-14. Review.

PMID:
15841373
[PubMed - indexed for MEDLINE]
13.

Current status of therapy of solid tumors.

Jhanwar YS, Divgi C.

J Nucl Med. 2005 Jan;46 Suppl 1:141S-50S.

PMID:
15653662
[PubMed - indexed for MEDLINE]
Free Article
14.

Pretargeted radioimmunotherapy with α-particle emitting radionuclides.

Lindegren S, Frost SH.

Curr Radiopharm. 2011 Jul;4(3):248-60. Review.

PMID:
22201711
[PubMed - indexed for MEDLINE]
15.

Antibody-based cancer therapies: back to "polyclonals"?

Paganelli G, De Santis R.

Eur J Nucl Med Mol Imaging. 2004 Nov;31(11):1453-5. Epub 2004 Jul 17. No abstract available.

PMID:
15258701
[PubMed - indexed for MEDLINE]
16.

Advances in cancer therapy with radiolabeled monoclonal antibodies.

Goldenberg DM, Sharkey RM.

Q J Nucl Med Mol Imaging. 2006 Dec;50(4):248-64. Review.

PMID:
17043623
[PubMed - indexed for MEDLINE]
Free Article
17.

Towards translation of 212Pb as a clinical therapeutic; getting the lead in!

Yong K, Brechbiel MW.

Dalton Trans. 2011 Jun 21;40(23):6068-76. doi: 10.1039/c0dt01387k. Epub 2011 Mar 4.

PMID:
21380408
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Radioimmunotherapy for acute leukemia.

Burke JM, Jurcic JG, Scheinberg DA.

Cancer Control. 2002 Mar-Apr;9(2):106-13. Review.

PMID:
11965231
[PubMed - indexed for MEDLINE]
Free Article
19.

Perspectives on cancer therapy with radiolabeled monoclonal antibodies.

Sharkey RM, Goldenberg DM.

J Nucl Med. 2005 Jan;46 Suppl 1:115S-27S. Review.

PMID:
15653660
[PubMed - indexed for MEDLINE]
Free Article
20.

Initial evaluation of (227)Th-p-benzyl-DOTA-rituximab for low-dose rate alpha-particle radioimmunotherapy.

Dahle J, Borrebaek J, Melhus KB, Bruland OS, Salberg G, Olsen DR, Larsen RH.

Nucl Med Biol. 2006 Feb;33(2):271-9.

PMID:
16546683
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk